Disturbances of STAT6 signaling in steroid-free asthma

V. N. Mineev, L. N. Sorokina (Saint Petersburg, Russian Federation)

Source: Annual Congress 2006 - Asthma - miscellaneous issues
Session: Asthma - miscellaneous issues
Session type: Electronic Poster Session
Number: 2900
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. N. Mineev, L. N. Sorokina (Saint Petersburg, Russian Federation). Disturbances of STAT6 signaling in steroid-free asthma. Eur Respir J 2006; 28: Suppl. 50, 2900

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Analysis of cytokine signaling through the STAT6 activation in patients with atopic steroid-free asthma
Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy
Year: 2007


Notch pathway signaling in asthma
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006


Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008


Nlrc5 is involved in allergic airway inflammation and negatively regulates inflammatory signaling pathway via TLR2/NF-?B.
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018

Interleukin-17 cytokine signalling in patients with asthma
Source: Eur Respir J 2014; 44: 1319-1331
Year: 2014



Activation of TGFβ/Smad signalling pathway in induced sputum of asthmatic children
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009

A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002

Inhibition of VEGF blocks the activation of TGF-β1 through a PI3K/Akt signaling pathway in allergic airway disease of mice
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007


Impaired MAP kinase-dependent modulation of transcription factor T-bet in T-lymphocytes from asthmatics - role of dexamethasone
Source: Eur Respir J 2005; 26: Suppl. 49, 233s
Year: 2005

Dysregulation of ZFP36L1 and ZFP36L2 in severe asthma alters epithelial integrity and dampens genome-wide glucocorticoid responses
Source: Virtual Congress 2021 – Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier
Year: 2021



Role of IL-33 signaling in pollutant-induced allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018


CREB signaling and chromatin remodeling during corticosteroid and theophylline therapy of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 355s
Year: 2007

Role of dexamethasone and MAPkinases ERK and p38MAPK on T-bet expression and IFNγ release in peripheral blood lymphocytes from atopic asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 229s
Year: 2006

Improvement of allergic asthma symptoms by targeting STAT6 with siRNA
Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment
Year: 2008


Suppressor of cytokine signalling 1 (SOCS1) and asthma exacerbations
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018


Activation of IL-32 pathway in COPD
Source: Annual Congress 2008 - Cell biology of asthma and COPD
Year: 2008

Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma
Source: Eur Respir J 2010; 35: 750-756
Year: 2010



PP103 – Dysregulation of ZFP36L1 and ZFP36L2 in asthma alters epithelial integrity and genome-wide glucocorticoid responses
Source: ERS Lung Science Conference 2021
Year: 2021

Low-level laser therapy effect on the bronchial hyperresponsiveness and the chronic allergy airway inflammation is driven to RhoA signaling and STAT-6
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013

New aspects of the action of IL-4 on the activity of the transcription factor STAT6 in allergic and non-allergic asthma
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009